<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04460313</url>
  </required_header>
  <id_info>
    <org_study_id>ACT0806</org_study_id>
    <nct_id>NCT04460313</nct_id>
  </id_info>
  <brief_title>Nasopharyngeal Carriage of S. Pneumoniae</brief_title>
  <official_title>Observatoire du Portage rhinopharyngé de Streptococcus Pneumoniae (Sp) Chez Des Nourrissons Ayant Une Otite Moyenne aiguë (OMA) et Sains - Etude Ancillaire Sur la détection Des Porteurs de E Coli BLSE</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Association Clinique Thérapeutique Infantile du val de Marne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Association Clinique Thérapeutique Infantile du val de Marne</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This nasopharyngeal (NP) carriage surveillance study was requested by the European Agency for
      the Evaluation of Medicinal Products as a post-licensing commitment to determine whether the
      use of the pneumococcal conjugate vaccines (PCVs) including 7 then 13 valents (introduced in
      2001 and 2010, respectively) caused a shift in the distribution of Streptococcus pneumoniae
      serotypes in children with acute otitis media and modified the resistance of this bacterial
      species to antibiotics.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Since September 2001, 121 pediatricians who are part of a research and teaching network
      (ACTIV) throughout France participated at this prospective study. From October to June of
      each subsequent year, children of both sexes suffering from suppurative acute otitis media
      (AOM) with fever and/or otalgia (in order to increase the probability of pneumococcal AOM),
      aged 6 to 24 months, were enrolled.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 11, 2001</start_date>
  <completion_date type="Anticipated">September 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>multicenter nationwide prospective cohort</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>S. Pneumoniae colonisation to detect emerging serotypes</measure>
    <time_frame>at inclusion</time_frame>
    <description>The percentage of children colonised by non vaccine serotypes -</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Detect the emergence of resistance S. pneumoniae</measure>
    <time_frame>at inclusion</time_frame>
    <description>Percentage of penicillin resistant S. pneumoniae</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the rhinopharyngeal carriage of other bacteria</measure>
    <time_frame>at inclusion</time_frame>
    <description>Haemophilus influenzae, Moraxella Catarrhalis, and Staphylococcus aureus in AOM group and healthy children.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Detect the emergence of new serotypes</measure>
    <time_frame>at inclusion</time_frame>
    <description>&gt; 10 Percent of isolated Sp, 5 percent of carrier children</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">25000</enrollment>
  <condition>Nasopharyngeal Carriage</condition>
  <condition>Children, Only</condition>
  <condition>Antibiotic Resistant Strain</condition>
  <arm_group>
    <arm_group_label>prospective cohort</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Nasopharyngeal sample for each enrrolled children</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>nasopharyngeal sample</intervention_name>
    <description>nasopharyngeal swabs from children with acute otitis media aged 6 to 24 months. The swabs were analyzed by the French National Reference Centre for Pneumococci.</description>
    <arm_group_label>prospective cohort</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  both sexes

          -  suffering from suppurative AOM

          -  age: 6 months to 24 months for AOM

          -  age: 6 months to 15 years for healthy children

          -  informed consent from parents or guardians

        Exclusion Criteria:

          -  Children with antibiotic treatment within 7 days before enrolment,

          -  severe underlying disease,

          -  inclusion in the study during the previous 12 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Cohen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Association Clinique Thérapeutique Infantile du val de Marne</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Corinne Levy, MD</last_name>
    <phone>0033148850404</phone>
    <email>corinne.levy@activ-france.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stéphane Béchet, MsC</last_name>
    <phone>0033148850404</phone>
    <email>stephane.bechet@activ-france.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>ACTIV</name>
      <address>
        <city>Créteil</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Corinne Levy, MD</last_name>
      <phone>0033148850404</phone>
      <email>corinne.levy@activ-france.fr</email>
    </contact>
    <contact_backup>
      <last_name>Stéphane Béchet, MSc</last_name>
      <phone>0033148850404</phone>
      <email>stephane.bechet@activ-france.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>https://www.activ-france.com/fr/publications</url>
    <description>ACTIV publications</description>
  </link>
  <results_reference>
    <citation>Ouldali N, Cohen R, Levy C, Gelbert-Baudino N, Seror E, Corrard F, Vie Le Sage F, Michot AS, Romain O, Bechet S, Bonacorsi S, Angoulvant F, Varon E. Pneumococcal susceptibility to antibiotics in carriage: a 17 year time series analysis of the adaptive evolution of non-vaccine emerging serotypes to a new selective pressure environment. J Antimicrob Chemother. 2019 Oct 1;74(10):3077-3086. doi: 10.1093/jac/dkz281.</citation>
    <PMID>31280295</PMID>
  </results_reference>
  <results_reference>
    <citation>Rybak A, Levy C, Bonacorsi S, Béchet S, Vié le Sage F, Elbez A, Varon E, Cohen R. Antibiotic Resistance of Potential Otopathogens Isolated From Nasopharyngeal Flora of Children With Acute Otitis Media Before, During and After Pneumococcal Conjugate Vaccines Implementation. Pediatr Infect Dis J. 2018 Mar;37(3):e72-e78. doi: 10.1097/INF.0000000000001862.</citation>
    <PMID>29227464</PMID>
  </results_reference>
  <results_reference>
    <citation>Birgy A, Bidet P, Levy C, Sobral E, Cohen R, Bonacorsi S. CTX-M-27-Producing Escherichia coli of Sequence Type 131 and Clade C1-M27, France. Emerg Infect Dis. 2017 May;23(5):885. doi: 10.3201/eid2305.161865.</citation>
    <PMID>28418829</PMID>
  </results_reference>
  <results_reference>
    <citation>Cohen R, Varon E, Doit C, Schlemmer C, Romain O, Thollot F, Béchet S, Bonacorsi S, Levy C. A 13-year survey of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 and PCV13 implementation. Vaccine. 2015 Sep 22;33(39):5118-26. doi: 10.1016/j.vaccine.2015.08.010. Epub 2015 Aug 11.</citation>
    <PMID>26271823</PMID>
  </results_reference>
  <results_reference>
    <citation>Cohen R, Levy C, Bonnet E, Thollot F, Boucherat M, Fritzell B, Derkx V, Bingen E, Varon E. Risk factors for serotype 19A carriage after introduction of 7-valent pneumococcal vaccination. BMC Infect Dis. 2011 Apr 18;11:95. doi: 10.1186/1471-2334-11-95.</citation>
    <PMID>21501471</PMID>
  </results_reference>
  <results_reference>
    <citation>Cohen R, Bingen E, Levy C, Thollot F, Boucherat M, Derkx V, Varon E. Nasopharyngeal flora in children with acute otitis media before and after implementation of 7 valent pneumococcal conjugate vaccine in France. BMC Infect Dis. 2012 Mar 7;12:52. doi: 10.1186/1471-2334-12-52.</citation>
    <PMID>22397629</PMID>
  </results_reference>
  <results_reference>
    <citation>Levy C, Vie le Sage F, Varon E, Chalumeau M, Grimprel E, Cohen R. Pediatric Ambulatory and Hospital Networks for Surveillance and Clinical Epidemiology of Community-Acquired Infections. J Pediatr. 2018 Mar;194:269-270.e2. doi: 10.1016/j.jpeds.2017.11.050. Epub 2018 Feb 22.</citation>
    <PMID>29637893</PMID>
  </results_reference>
  <results_reference>
    <citation>Vermee Q, Cohen R, Hays C, Varon E, Bonacorsi S, Bechet S, Thollot F, Corrard F, Poyart C, Levy C, Raymond J. Biofilm production by Haemophilus influenzae and Streptococcus pneumoniae isolated from the nasopharynx of children with acute otitis media. BMC Infect Dis. 2019 Jan 11;19(1):44. doi: 10.1186/s12879-018-3657-9.</citation>
    <PMID>30634919</PMID>
  </results_reference>
  <results_reference>
    <citation>Birgy A, Madhi F, Jung C, Levy C, Cointe A, Bidet P, Hobson CA, Bechet S, Sobral E, Vuthien H, Ferroni A, Aberrane S, Cuzon G, Beraud L, Gajdos V, Launay E, Pinquier D, Haas H, Desmarest M, Dommergues MA, Cohen R, Bonacorsi S; Group of the National Observatory of Urinary tract Infection due to ESBL-producing Enterobacteriaceae in children . Diversity and trends in population structure of ESBL-producing Enterobacteriaceae in febrile urinary tract infections in children in France from 2014 to 2017. J Antimicrob Chemother. 2020 Jan 1;75(1):96-105. doi: 10.1093/jac/dkz423.</citation>
    <PMID>31617912</PMID>
  </results_reference>
  <results_reference>
    <citation>Mizrahi A, Cohen R, Varon E, Bonacorsi S, Bechet S, Poyart C, Levy C, Raymond J. Non typable-Haemophilus influenzae biofilm formation and acute otitis media. BMC Infect Dis. 2014 Jul 19;14:400. doi: 10.1186/1471-2334-14-400.</citation>
    <PMID>25037572</PMID>
  </results_reference>
  <results_reference>
    <citation>Birgy A, Levy C, Bidet P, Thollot F, Derkx V, Béchet S, Mariani-Kurkdjian P, Cohen R, Bonacorsi S. ESBL-producing Escherichia coli ST131 versus non-ST131: evolution and risk factors of carriage among French children in the community between 2010 and 2015. J Antimicrob Chemother. 2016 Oct;71(10):2949-56. doi: 10.1093/jac/dkw219. Epub 2016 Jun 20.</citation>
    <PMID>27330068</PMID>
  </results_reference>
  <results_reference>
    <citation>Hau I, Levy C, Caeymaex L, Cohen R. Impact of pneumococcal conjugate vaccines on microbial epidemiology and clinical outcomes of acute otitis media. Paediatr Drugs. 2014 Feb;16(1):1-12. doi: 10.1007/s40272-013-0044-2.</citation>
    <PMID>23963858</PMID>
  </results_reference>
  <results_reference>
    <citation>Birgy A, Cohen R, Levy C, Bidet P, Courroux C, Benani M, Thollot F, Bingen E. Community faecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae in French children. BMC Infect Dis. 2012 Nov 21;12:315. doi: 10.1186/1471-2334-12-315.</citation>
    <PMID>23171127</PMID>
  </results_reference>
  <results_reference>
    <citation>Caeymaex L, Varon E, Levy C, Béchet S, Derkx V, Desvignes V, Doit C, Cohen R. Characteristics and outcomes of acute otitis media in children carrying streptococcus pneumoniae or haemophilus influenzae in their nasopharynx as a single otopathogen after introduction of the heptavalent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2014 May;33(5):533-6. doi: 10.1097/INF.0000000000000213.</citation>
    <PMID>24263220</PMID>
  </results_reference>
  <results_reference>
    <citation>Cohen R, Levy C, Bingen E, Koskas M, Nave I, Varon E. Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media. Pediatr Infect Dis J. 2012 Mar;31(3):297-301. doi: 10.1097/INF.0b013e318247ef84.</citation>
    <PMID>22330166</PMID>
  </results_reference>
  <results_reference>
    <citation>Cohen R, Levy C, Bingen E, Bechet S, Derkx V, Werner A, Koskas M, Varon E. [Nasopharyngeal carriage of children 6 to 60 months during the implementation of the 13-valent pneumococcal conjugate vaccine]. Arch Pediatr. 2012 Oct;19(10):1132-9. doi: 10.1016/j.arcped.2012.07.013. Epub 2012 Aug 24. French.</citation>
    <PMID>22925540</PMID>
  </results_reference>
  <results_reference>
    <citation>Cohen R, Levy C, Thollot F, de La Rocque F, Koskas M, Bonnet E, Fritzell B, Varon E. Pneumococcal conjugate vaccine does not influence Staphylococcus aureus carriage in young children with acute otitis media. Clin Infect Dis. 2007 Dec 15;45(12):1583-7. doi: 10.1086/523734. Erratum in: Clin Infect Dis. 2008 Feb 1;46(3):489.</citation>
    <PMID>18190319</PMID>
  </results_reference>
  <results_reference>
    <citation>Cohen R, Levy C, de La Rocque F, Gelbert N, Wollner A, Fritzell B, Bonnet E, Tetelboum R, Varon E. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media. Pediatr Infect Dis J. 2006 Nov;25(11):1001-7.</citation>
    <PMID>17072121</PMID>
  </results_reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>June 19, 2020</study_first_submitted>
  <study_first_submitted_qc>July 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 7, 2020</study_first_posted>
  <last_update_submitted>July 8, 2020</last_update_submitted>
  <last_update_submitted_qc>July 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pneumococcal conjugate vaccine</keyword>
  <keyword>Streptococcus pneumoniae</keyword>
  <keyword>Carriage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

